Case studies of elderly patients with non-Hodgkin's lymphoma

Main Article Content

Stefano Luminari *
Massimo Federico
(*) Corresponding Author:
Stefano Luminari | sluminari@unimore.it

Abstract

The treatment of patients with non- Hodgkin’s lymphoma (NHL) is often the treatment of elderly patients, as most patients are older than 65 years at diagnosis. These elderly patients present particular therapeutic challenges, because they may be more frail and at greater risk of treatment-related toxicity, especially anthracycline-related cardiotoxicity, than younger patients. The following two case studies illustrate the challenges and therapeutic decision-making in managing elderly patients with an aggressive and an indolent form of lymphoma.

Downloads month by month

Downloads

Download data is not yet available.

Article Details